Precision Medicine in Type 2 Diabetes & Cardiovascular disease 31 August–1 September 2016 at Hotel Skansen in Båstad, Sweden

Arkiv alla nyheter

Precision Medicine in Type 2 Diabetes & Cardiovascular disease 31 August–1 September 2016 at Hotel Skansen in Båstad, Sweden

Dear colleagues,

This is an invitation to a meeting in southern Sweden this summer Aug 31st and Sept 1st on precision medicine in type 2 diabetes and CVD http://www.sls.se/precisionmedicine

Nyhetsinfo

www red DiabetiologNytt

We have put together an outstanding programme, which I believe will be of high interest to you. This will be a 2-day, single-track meeting of around 200 speakers and delegates and promises to be a great platform for discussion and future collaboration.

Please consider signing-up and encouraging your colleagues and fellows to do the same.

With best wishes,

Paul Franks and Peter M Nilsson

Paul W. Franks PhD (Cantab) MPhil (Cantab) MS FTOS | Professor & Head of Unit

Genetic & Molecular Epidemiology Unit, Lund University Diabetes Centre, Malmö, Sweden

Professor (adjunct) – Harvard School of Public Health, Boston, MA

www.ludc.med.lu.se/game

www.hsph.harvard.edu/faculty/paul-franks/

Berzelius symposium 91

Precision Medicine in Type 2 Diabetes & Cardiovascular disease

31 August–1 September 2016 at Hotel Skansen in Båstad, Sweden

More information and registration: http://www.sls.se/precisionmedicine/

Wednesday, August 30th
Registration for delegates start at 4 pm.

Wednesday, August 31st

09.00-09.15 Welcome and introduction.
Paul Franks, Lund University Diabetes Center, Sweden

09.15-10.00 Precision medicine: where are we and where are we going?
Leif Groop, Lund University Diabetes Center, Sweden

10.00-10.45 What industry wants from academic partnerships in precision medicine.
Hartmut Ruetten, Sanofi, Germany

10.45-11.15 Coffee break (poster session 1)

11.15-12.15 Why national initiatives and global collaborations are needed and how they are taking shape. Phil Smith, NIDDK, US

12.15-13.30 Lunch

13.30-14.15 The genetics of therapeutic response. Jose Florez, Harvard, US

14.15-15.00 Is genotype-guided lifestyle therapy on the horizon?
Anna Krook, Karolinska Institutet, Sweden

15.00-15.30 Coffee break (poster session 2)

15.30-16.15 Societal and ethical implications of genetically-guided medicine.
Andy Miah, Salford, UK

16.15-17.00 Functional genomics. Manolis Kellis, MIT, US

17.00-17.45 Elucidating mechanisms. Anna Gloyn, Oxford, UK

19.00-22.00 Symposium dinner

Thursday, September 1st

09.00-09.45 What can monogenic obesity teach us about disease stratification and personalized treatment in type 2 diabetes? Giles Yeo, Cambridge, UK

09.45-10.30 What can monogenic diabetes teach us about disease stratification and personalized treatment in type 2 diabetes? Andrew Hattersley, Exeter, UK

10.30-11.15 Making precision medicine personal. Mike Snyder, Stanford, US

11.15-12.00 Commercialization of precision medicine. Adam Auton, 23andMe, US

12.00-13.00 Lunch

13.00-14.00 Debate: precision medicine will transform patient care for the better:
for: Ewan Pearson, University of Dundee, UK
against: Simon Griffin, University of Cambridge, UK

14.00-14.45 Nature genetics’ view of the prospects for precision medicine.
Myles Axton, Cheif Editor, Nature Genetics

14.45-15.00 Coffee break (poster session 3)

15.00-15.45 Innovation in big data analysis. Mark McCarthy, Oxford, UK

15.45-16.00 Closing remarks. Paul Franks